Studies on the interaction of placental anticoagulant protein I, β2glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 194-201

  Pierangeli, Silvia S ^a   Dean, Jacqueline ^b   Goldsmith, George H ^b   Branch, D Ware ^b   Gharavi, Azzudin ^b   Harris, E Nigel ^b  

^a University of Louisville School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030205394     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90011-6     Document Type: Article

References (40)

1. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-6.
2. Thiagarajan P, Pengo V, Shapiro SS. The use of dilute Russell viper venom time for the diagnosis of LAs. Blood 1986; 68:869-77.
3. Harris EN, Gharavi AE, Tincani AE, Chan JKH, Englert H. Affinity purified anticardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985;17:155-62.
4. Harris EN, Gharavi AE, Loizou S, Derue G, Chan JKH, Hughes GRV. Cross-reactivity of anti-phospholipid antibodies. J Clin Lab Immunol 1985;16:1-6.
5. Pengo V, Biasiolo A. Purification of anticardiolipin and LA activities by using cardiolipin immobilized on agarose beads. Thromb Res 1993;72:423-30.
6. McNeil HP, Chesterman CN, Krilis SA. Binding specificity of LAs and anticardiolipin antibodies. Thromb Res 1988;52: 609-19.
7. Violi F, Valesini G, Ferro D, Tincani A, Balestrieri G, Balsano F. Anticoagulant activity of anticardiolipin antibodies. Thromb Res 1986;44:543-7.
8. Brandt JT. Assays for phospholipid-dependent formation of thrombin and factor Xa: a potential method for quantifying LA activity. Thromb Haemost 1991;66:453-8.
9. Galli M, Beguin S, Lindout T, Hemker CH. Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with LAs. Br J Haematol 1989;72: 549-55.
10. Sammaritano LR, Gharavi AE, Soberano C, Levy RA, Lockshin MD. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol 1992; 12:27-35.
11. Pierangeli SS, Harris EN, Goldsmith GH, Gharavi AE, Branch DW, Dean WL. Are immunoglobulins with LA activity specific for phospholipids? Br J Haematol 1993;85:124-32.
12. 2glycoprotein 1. Br J Haematol 1994;87:548-54.
13. Pierangeli SS, Goldsmith GH, Krnic S, Harris EN. Differences in functional activity of anticardiolipin antibodies from patients with syphilis and the antiphospholipid syndrome. Infect Immun 1994;62:4081-4.
14. Fleck RA, Rapaport SE, Rao LVM. Anti-prothrombin antibodies and the LA. Blood 1988;72:512-9.
15. 2glycoprotein 1 in the expression of LA activity. Blood 1994;83:2878-92.
16. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant (LA) IgGs are not directed to phospholipids only but to a complex lipid-bound human prothrombin. Thromb Haemost 1991;66:629-32.
17. 2glycoprotein 1 is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992;68:297-300.
18. 2glycoprotein 1. Thromb Haemost 1992;67:499-502.
19. 2glycoprotein 1. J Clin Invest 1992; 90:1100-4.
20. Galli M, Comfurius P, Maasen C, Heinker HC, Van-Breda Vriesman PJC, Barbui T, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;336:1544-7.
21. 2glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179;457-62.
22. 2glycoprotein 1 as an antigen. Br J Haematol 1992;81:568-73.
23. 2glycoprotein 1 with lupus circulating anticoagulant and thrombosis in SLE. Am J Med 1992;93:181-6.
24. 2glycoprotein 1 in the absence of phospholipid. J Immunol 1995;154:954-60.
25. 2glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci 1990;87:4120-4.
26. 2glycoprotein 1 (apolipoprotein H) as cofactor. J Rheumatol 1992;48:484-6.
27. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
28. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry 1987;26:5572-8.
29. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-1, a member of the lipocortin family. J Biol Chem 1989;264:7944-9.
30. Cassulis P, Magasic MW, DeBari VA. Ligand affinity chromatographic separation of serum IgG on recombinant protein G silica. Clin Chem 1991;37:882-6.
31. 2glycoprotein 1 (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984;16:511-5.
32. 2glycoprotein 1 enhances cardiolipin binding activity but is not the target antigen for antiphospholipid antibodies. Br J Haematol 1992;82:565-70.
33. Harris EN, Pierangeli SS, Birch D. Anticardiolipin wet workshop report: Fifth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol 1994;101:616-24.
34. Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4, 1986. Clin Exp Immunol 1987;68:215-22.
35. 2glycoprotein 1. Biochim Biophys Acta 1986;884:142-4.
36. Berenbaum MC. Criteria for analyzing interations between biologically active agents. Adv Cancer Res 1981;35:269-335.
37. Harris EN, Pierangeli SS. What is the "true" antigen for antiphospholipid antibodies [letter]? Lancet 1990;336:1550.
38. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of LAs and other "antiphospholipid" autoantibodies. Blood 1994;84:2854.
39. Vermylen J, Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes. J Lab Clin Med 1992;120: 10-1.
40. Pengo V, Heine MM, Thiagarajan P, Shapiro SS. Immunological specificity and mechanism of action of IgG LAs. Blood 1987;70:69-76.